arrow
F

Fang Sun

Center for Hypertension and Metabolic Diseases
H指数:26
被引数:3,750

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase III, randomized, controlled noninferiority trial to study the efficacy and safety of imipenem/cilastatin/relebactam (IMI/REL) vs piperacillin/tazobactam (PIP/TAZ) in patients with hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP)

一项III期、随机、对照非劣效性试验,旨在研究比较碳青霉烯类抗生素亚胺培南/西司他丁/雷莫拉巴(IMI/REL)与哌拉西林/他唑巴坦(PIP/TAZ)在治疗医院获得性细菌性肺炎(HABP)或呼吸机相关性细菌性肺炎(VABP)患者中的有效性与安全性。

2025-04-010
OAAI
Comparative Outcomes of Adrenalectomy, Mineralocorticoid Receptor Antagonist, and Percutaneous Adrenal Ablation for Primary Aldosteronism: A Systematic Review and Network Meta-Analysis

肾上腺切除术、盐皮质激素受体拮抗剂和经皮肾上腺消融术治疗原发性醛固酮增多症的对比结局:一项系统评价和网络Meta分析

2025-03-180
PRE
Chinese expert consensus on the management of hypertension in adults with type 2 diabetes
2024-11-122
OA